Products Antibodies Monoclonal Antibodies Anti-ETFDH Monoclonal Antibody for WB, IF, IHC, ELISA - Q16134

No Image

Monoclonal Antibodies

Anti-ETFDH Monoclonal Antibody for WB, IF, IHC, ELISA - Q16134

Item Number : CM0011513

Price varies based on specs and customizations


Application
WB, IF/ICC, IF-P, IHC-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
68kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name [KD Validated] ETFDH Rabbit mAb
Remarks/Alias MADD; ETFQO
Species Human
GeneID 2110
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 480-617 of human ETFDH (NP_004444.2)
Source Rabbit
Category Monoclonal Antibodies
Application WB, IF/ICC, IF-P, IHC-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS Q16134
Protein Weight 68kDa
Shipping Ice bag

Biological Background: ETFDH Function and Localization

  • ETFDH (electron transfer flavoprotein-ubiquinone oxidoreductase, also known as ETF dehydrogenase) is a mitochondrial inner membrane flavoprotein that couples fatty acid β-oxidation and amino acid catabolism to the respiratory chain by transferring electrons from electron transfer flavoprotein (ETF) to ubiquinone.
  • The enzyme contains FAD and a 4Fe-4S cluster, functioning as an oxidoreductase and participating in electron transport and lipid metabolism.
  • Mutations in ETFDH cause glutaric aciduria type II (multiple acyl-CoA dehydrogenase deficiency, MADD), highlighting its role in metabolic disease.
  • It localizes to the mitochondrial inner membrane, with a transit peptide directing its mitochondrial import.
  • Post-translational modifications include acetylation and phosphorylation, identified through proteomics; alternative splicing generates multiple isoforms.
  • The molecular weight predicted from the amino acid sequence is approximately 68.5 kDa, consistent with the observed 68 kDa band on western blots.

Experimental Guidance and Technical Tips

  • The immunogen covers the C-terminal region (aa 480–617) of human ETFDH, a segment conserved across human, mouse, and rat, supporting the cross-reactivity data.
  • For western blotting, a band near 68 kDa is expected; validate detection in relevant tissue or cell lysates and consider optimizing protein loading and blocking conditions.
  • When performing immunofluorescence or immunohistochemistry, ensure adequate permeabilization and, for IHC-P, optimize antigen retrieval; validate staining in appropriate positive and negative control samples.
  • In ELISA applications, test direct or sandwich formats and titrate the antibody to determine the optimal working concentration for your specific assay.
  • Given the mitochondrial localization of ETFDH, subcellular fractionation or mitochondrial enrichment may improve detection sensitivity in certain sample types.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio offers a comprehensive range of IVD raw materials and technical services to support diagnostic manufacturers and researchers from concept to clinical application. For projects investigating mitochondrial disorders, electron transport chain defects, or metabolic pathways, we provide validated antibody pairs, optimized recombinant antibodies, and bulk ancillary reagents for high-throughput and clinical assay development. Contact our team to discuss custom sourcing for rare-target raw materials and one-stop supply solutions tailored to your workflow.

View more faqs for this product

Product Datasheet

Anti-ETFDH Monoclonal Antibody for WB, IF, IHC, ELISA - Q16134


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!